- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01198470
TRIUMPH Lumbar Artificial Disc IDE: A Pilot Study
A Prospective Clinical Investigation of the TRIUMPH Lumbar Disc: A Pilot Study
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Georgia
-
Savannah, Georgia, United States, 31403
- Memorial Health University Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Degenerative Disc Disease in one vertebral level between L1 and S1
- Able to understand and sign informed consent
- Had at least 6 months of conservative treatment
- Oswestry Disability Index Score of at least 30 (one a 100 point scale)
- Other inclusion criteria as specified in approved IDE protocol
Exclusion Criteria:
- Bilateral leg pain
- Back or leg pain of unknown etiology
- Prior fusion surgery or another spinal device implanted at any other lumbar level
- Osteoporosis or osteopenia
- Other exclusion criteria as specified in approved IDE protocol
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: TRIUMPH® Artificial Disc
Treatment of degenerative disc disease with the TRIUMPH Lumbar Artificial Disc.
This is a non-randomized pilot study with only one arm (no control).
|
The TRIUMPH® Lumbar Artificial Disc is an articulating artificial disc inserted using a posterolateral approach to the lumbar spine.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Number of Participants With a Change of at Least 15 Points in Pain/Disability Using the Oswestry Disability Index (ODI) Score at 24 Months Compared With the Score at Baseline
Time Frame: 24 months
|
The Oswestry Disability Index (ODI) is a commonly used outcome-measure questionnaire for low back pain in a hospital setting.
It is a self-administered questionnaire divided into ten sections designed to assess limitations of various activities of daily living.
Each section is scored on a 0-5 scale, 5 representing the greatest disability.
The scores for all questions answered are summed, then multiplied by two to obtain the index (range 0 to 100).
Zero is equated with no disability and 100 is the maximum disability possible.
|
24 months
|
Number of Participants With No Device Failures
Time Frame: 24 months
|
Any device requiring surgical revision, reoperation, removal or supplemental fixation will be considered a device failure
|
24 months
|
Number of Participants With Major Complications Defined as Major Vessel Injury or Neurological Damage
Time Frame: 24 months
|
Major vessel injury is defined as injury of the aorta or vena cava or other major vessels (e.g.
iliac arteries, superior rectal artery, iliac veins, and their branches), caused by the surgery or device, resulting in significant blood loss or requiring additional surgery to correct.
Neurological damage is defined as damage to the spinal cord or a nerve root caused by the surgery or device, resulting in neurologic deficit that persists for more than 3 months and is without improvement, is progressive, or involves motor loss.
Major complications are reported on adverse event case report forms.
|
24 months
|
Number of Participants Determined to Have a Normal Neurological Status
Time Frame: 24 months
|
Neurological status was assessed using a neurological status scale, which is based on four types of measurement parameters: motor, sensory, reflexes, and straight leg raise. The method for summarizing neurological status is described below. Each parameter (i.e. motor, sensory, reflexes, straight leg raise) is coded as follows: Motor 0 Total Paralysis
Sensory 0 Absent
Reflexes 0 Absent or Trace
Straight Leg Raise 0 0° - 70° (Abnormal) 1 > 70°-90° (Normal) If all evaluations for the parameter are determined to be normal, then the parameter is given a normal status. If any evaluations for the parameter are abnormal, then the parameter is given an abnormal status. |
24 months
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- G090143
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Lumbar Degenerative Disc Disease
-
NuVasiveCompleted
-
NuVasiveCompleted
-
Spine BioPharma, IncMCRARecruitingLumbar Degenerative Disc DiseaseUnited States
-
Synthes USA HQ, Inc.CompletedLumbar Degenerative Disc Disease
-
NYU Langone HealthActive, not recruitingLumbar Degenerative Disc DiseaseUnited States
-
Bioventus LLCTerminatedLumbar Degenerative Disc Disease
-
Justin Parker Neurological InstituteTerminated
-
OAD OrthopaedicsCentral DuPage Hospital; Halifax Biomedical Inc.Unknown
-
Eisai China Inc.Completed
-
Foundation for Orthopaedic Research and EducationCoreLink, LLCCompletedDegenerative Disc Disease Lumbar
Clinical Trials on TRIUMPH® Lumbar Artificial Disc
-
SpinalMotionTerminatedDegenerative Disc DiseaseUnited States
-
SpinalMotionTerminatedDegenerative Disc Disease (DDD)United States
-
Aesculap Implant SystemsCompletedDegenerative Disc DiseaseUnited States
-
Karolinska InstitutetCompletedSciatica | Intervertebral Disc Displacement
-
HaoxuanZhangRecruitingGene Product Sequence Variation | Lumbar Degenerative DiseasesChina
-
NuVasiveEnrolling by invitationDegenerative Disc Disease | Cervical Disc DiseaseUnited States
-
SC MedicaRecruiting
-
National Institute of Technology, Hiroshima CollegeCompletedOther Intervertebral Disc Degeneration, Lumbar Region
-
DePuy InternationalTerminatedCervical Degenerative Disc DiseaseAustralia, Germany, Italy, Malaysia, Netherlands, Spain, United Kingdom